Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

NCT05358938

Conditions: Adenocarcinoma, Behavior, Carcinoma, +24 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS)

NCT00907868

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France

View Trial Details

Active, Not Recruiting

Liver Function Investigation With SPECT

NCT02967848

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Royal North Shore Hospital St Leonards, New South Wales, Australia

View Trial Details

Active, Not Recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273

Conditions: Adenocarcinoma, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +77 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial

NCT07380633

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Active, Not Recruiting

Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative

NCT05113186

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: NAHON Bobigny, France

View Trial Details

Active, Not Recruiting

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

NCT03474497

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations: UC Davis Medical Center Sacramento, California, United States

University of California Davis Medical Center Sacramento, California, United States

View Trial Details

Active, Not Recruiting

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

NCT01918683

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Loyola University Medical Center Maywood, Illinois, United States

Oregon Health & Science University Portland, Oregon, United States

Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

NCT05340673

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +8 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

NCT02432963

Conditions: Adenocarcinoma, Adult Solid Neoplasm, Bladder Carcinoma, +74 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions